FdaApplication
NDA 214522
Identifiers
- fda_app_no: NDA214522
Properties
| Property | Value |
|---|---|
| applicant_name | CMP DEVELOPMENT LLC |
| application_type | NDA |
| approval_date | 2022-06-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TADLIQ | TADALAFIL | 20MG/5ML | SUSPENSION;ORAL |
1 product